On this scenario, the relationship between obesity and BRCA1 mutations in UC patients should be further explored, even due to the necessity of understanding the potential role of Poly (ADP-ribose) polymerase (PARP) inhibitors in this tumor. The gene discussed is BRCA1; the disease is obesity due to melanocortin 4 receptor deficiency.